P-272 The combination of azacitidine and lenalidomide is deliverable without unexpected toxicity; interim safety results of the ALLG MDS4 randomised trial.

Saved in:
Bibliographic Details
Title: P-272 The combination of azacitidine and lenalidomide is deliverable without unexpected toxicity; interim safety results of the ALLG MDS4 randomised trial.
Authors: Kenealy, M., Seymour, J.F., Benson, W., Stevenson, W., Eek, R., Zantomio, D., Cunningham, I., Hiwase, D., Cowan, L., Zannino, D.
Source: Leukemia Research. May2013 Supplement, Vol. 37, pS145-S145. 1p.
Database: Academic Search Ultimate
Description
ISSN:01452126
DOI:10.1016/S0145-2126(13)70319-9